L. G. Amato, A. A. Vergani, M. Lassi, C. Fabbiani, S. Mazzeo, R. Burali, B. Nacmias, S. Sorbi, R. Mannella, A. Grippo, V. Bessi, A. Mazzoni
{"title":"阿尔茨海默病进展的个性化建模可通过脑电图记录估计神经变性的严重程度","authors":"L. G. Amato, A. A. Vergani, M. Lassi, C. Fabbiani, S. Mazzeo, R. Burali, B. Nacmias, S. Sorbi, R. Mannella, A. Grippo, V. Bessi, A. Mazzoni","doi":"10.1002/dad2.12526","DOIUrl":null,"url":null,"abstract":"Abstract INTRODUCTION Early identification of Alzheimer's disease (AD) is necessary for a timely onset of therapeutic care. However, cortical structural alterations associated with AD are difficult to discern. METHODS We developed a cortical model of AD‐related neurodegeneration accounting for slowing of local dynamics and global connectivity degradation. In a monocentric study we collected electroencephalography (EEG) recordings at rest from participants in healthy (HC, n = 17), subjective cognitive decline (SCD, n = 58), and mild cognitive impairment (MCI, n = 44) conditions. For each patient, we estimated neurodegeneration model parameters based on individual EEG recordings. RESULTS Our model outperformed standard EEG analysis not only in discriminating between HC and MCI conditions (F1 score 0.95 vs 0.75) but also in identifying SCD patients with biological hallmarks of AD in the cerebrospinal fluid (recall 0.87 vs 0.50). DISCUSSION Personalized models could (1) support classification of MCI, (2) assess the presence of AD pathology, and (3) estimate the risk of cognitive decline progression, based only on economical and non‐invasive EEG recordings. Highlights Personalized cortical model estimating structural alterations from EEG recordings. Discrimination of Mild Cognitive Impairment (MCI) and Healthy (HC) subjects (95%) Prediction of biological markers of Alzheimer's in Subjective Decline (SCD) Subjects (87%) Transition correctly predicted for 3/3 subjects that converted from SCD to MCI after 1y","PeriodicalId":516929,"journal":{"name":"Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring","volume":"310 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings\",\"authors\":\"L. G. Amato, A. A. Vergani, M. Lassi, C. Fabbiani, S. Mazzeo, R. Burali, B. Nacmias, S. Sorbi, R. Mannella, A. Grippo, V. Bessi, A. Mazzoni\",\"doi\":\"10.1002/dad2.12526\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract INTRODUCTION Early identification of Alzheimer's disease (AD) is necessary for a timely onset of therapeutic care. However, cortical structural alterations associated with AD are difficult to discern. METHODS We developed a cortical model of AD‐related neurodegeneration accounting for slowing of local dynamics and global connectivity degradation. In a monocentric study we collected electroencephalography (EEG) recordings at rest from participants in healthy (HC, n = 17), subjective cognitive decline (SCD, n = 58), and mild cognitive impairment (MCI, n = 44) conditions. For each patient, we estimated neurodegeneration model parameters based on individual EEG recordings. RESULTS Our model outperformed standard EEG analysis not only in discriminating between HC and MCI conditions (F1 score 0.95 vs 0.75) but also in identifying SCD patients with biological hallmarks of AD in the cerebrospinal fluid (recall 0.87 vs 0.50). DISCUSSION Personalized models could (1) support classification of MCI, (2) assess the presence of AD pathology, and (3) estimate the risk of cognitive decline progression, based only on economical and non‐invasive EEG recordings. Highlights Personalized cortical model estimating structural alterations from EEG recordings. Discrimination of Mild Cognitive Impairment (MCI) and Healthy (HC) subjects (95%) Prediction of biological markers of Alzheimer's in Subjective Decline (SCD) Subjects (87%) Transition correctly predicted for 3/3 subjects that converted from SCD to MCI after 1y\",\"PeriodicalId\":516929,\"journal\":{\"name\":\"Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring\",\"volume\":\"310 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/dad2.12526\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.12526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
摘要 引言 早期识别阿尔茨海默病(AD)对于及时开始治疗非常必要。然而,与阿尔茨海默病相关的皮质结构改变却很难辨别。方法 我们建立了一个与阿兹海默病相关的皮层神经变性模型,该模型考虑了局部动力学减缓和全局连通性退化。在一项单中心研究中,我们收集了健康(HC,n = 17)、主观认知能力下降(SCD,n = 58)和轻度认知障碍(MCI,n = 44)患者静息状态下的脑电图(EEG)记录。我们根据每个患者的脑电图记录估算了神经变性模型参数。结果 我们的模型不仅在区分HC和MCI情况(F1得分0.95 vs 0.75)方面优于标准脑电图分析,而且在识别脑脊液中具有AD生物学特征的SCD患者(召回率0.87 vs 0.50)方面也优于标准脑电图分析。讨论 个性化模型可(1)支持 MCI 分类,(2)评估是否存在 AD 病理,以及(3)仅根据经济和无创的脑电图记录来估计认知能力下降的风险。亮点 通过脑电图记录估计结构改变的个性化皮质模型。鉴别轻度认知功能障碍(MCI)和健康(HC)受试者(95%) 预测主观衰退(SCD)受试者的阿尔茨海默氏症生物标记物(87%) 1 年后从 SCD 转为 MCI 的 3/3 受试者的转归预测正确
Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings
Abstract INTRODUCTION Early identification of Alzheimer's disease (AD) is necessary for a timely onset of therapeutic care. However, cortical structural alterations associated with AD are difficult to discern. METHODS We developed a cortical model of AD‐related neurodegeneration accounting for slowing of local dynamics and global connectivity degradation. In a monocentric study we collected electroencephalography (EEG) recordings at rest from participants in healthy (HC, n = 17), subjective cognitive decline (SCD, n = 58), and mild cognitive impairment (MCI, n = 44) conditions. For each patient, we estimated neurodegeneration model parameters based on individual EEG recordings. RESULTS Our model outperformed standard EEG analysis not only in discriminating between HC and MCI conditions (F1 score 0.95 vs 0.75) but also in identifying SCD patients with biological hallmarks of AD in the cerebrospinal fluid (recall 0.87 vs 0.50). DISCUSSION Personalized models could (1) support classification of MCI, (2) assess the presence of AD pathology, and (3) estimate the risk of cognitive decline progression, based only on economical and non‐invasive EEG recordings. Highlights Personalized cortical model estimating structural alterations from EEG recordings. Discrimination of Mild Cognitive Impairment (MCI) and Healthy (HC) subjects (95%) Prediction of biological markers of Alzheimer's in Subjective Decline (SCD) Subjects (87%) Transition correctly predicted for 3/3 subjects that converted from SCD to MCI after 1y